Outcomes survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Cells, Cultured Bile Ducts, Intrahepatic Lymph Nodes

Organisms3

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout

Diseases62

Neoplasm Recurrence, Local Postoperative Complications Lung Neoplasms Recurrence Liver Neoplasms Adenocarcinoma Disease Progression Breast Neoplasms Lymphatic Metastasis Carcinoma, Squamous Cell Neoplasm Metastasis Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Brain Neoplasms Neoplasm Invasiveness Colorectal Neoplasms Neoplasms Pancreatic Neoplasms Esophageal Neoplasms Heart Arrest Carcinoma Disease Models, Animal Acute Disease Kidney Failure, Chronic Bone Neoplasms Rectal Neoplasms Bile Duct Neoplasms Sarcoma Prosthesis Failure Ovarian Neoplasms Stroke Melanoma Cholangiocarcinoma Myocardial Infarction Head and Neck Neoplasms Kidney Neoplasms Prostatic Neoplasms Chronic Disease Osteosarcoma Liver Failure Lymphoma, Non-Hodgkin Glioblastoma Sepsis Precursor Cell Lymphoblastic Leukemia-Lymphoma Nasopharyngeal Neoplasms Heart Failure Skin Neoplasms Out-of-Hospital Cardiac Arrest Cadaver Carcinoma, Renal Cell Colonic Neoplasms Leukemia, Myeloid, Acute Hodgkin Disease Ischemia Lymphoma, Large B-Cell, Diffuse Multiple Myeloma Glioma Soft Tissue Neoplasms Carcinoma, Small Cell Fetal Death Mouth Neoplasms

Chemicals and Drugs28

Tumor Markers, Biological Antineoplastic Agents Cisplatin Cyclophosphamide Vincristine Doxorubicin Fluorouracil Immunosuppressive Agents Prednisone Etoposide Methotrexate Deoxycytidine Biological Markers Paclitaxel Antimetabolites, Antineoplastic Vinblastine Antibodies, Monoclonal Carboplatin Bleomycin RNA, Messenger Cytarabine Antibodies, Monoclonal, Humanized Dacarbazine Neoplasm Proteins Cryoprotective Agents Tumor Suppressor Protein p53 Ifosfamide Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment112

Survival Rate Treatment Outcome Survival Analysis Disease-Free Survival Retrospective Studies Prognosis Follow-Up Studies Kaplan-Meier Estimate Neoplasm Staging Pregnancy Outcome Combined Modality Therapy Proportional Hazards Models Prospective Studies Risk Factors Antineoplastic Combined Chemotherapy Protocols Multivariate Analysis Cohort Studies Risk Assessment Predictive Value of Tests Registries Liver Transplantation Chemotherapy, Adjuvant Actuarial Analysis Reoperation Severity of Illness Index Immunohistochemistry Incidence Hepatectomy Radiotherapy, Adjuvant Chi-Square Distribution Kidney Transplantation Randomized Controlled Trials as Topic Remission Induction Life Tables Patient Selection Radiotherapy Dosage Transplantation, Homologous Logistic Models Treatment Failure Analysis of Variance Cardiopulmonary Resuscitation Hospital Mortality Regression Analysis Disease Models, Animal Probability Drug Administration Schedule Cause of Death Length of Stay Gastrectomy Clinical Trials as Topic Lymph Node Excision Radiotherapy Salvage Therapy Preoperative Care Chemoembolization, Therapeutic Tomography, X-Ray Computed SEER Program Statistics, Nonparametric Prosthesis Failure Cryopreservation Neoadjuvant Therapy Prosthesis Design Longitudinal Studies Drug Therapy, Combination Chemoradiotherapy Dose Fractionation Glasgow Outcome Scale Palliative Care Odds Ratio Feasibility Studies Reproducibility of Results Renal Dialysis Esophagectomy Reverse Transcriptase Polymerase Chain Reaction Postoperative Care Neoplasm Grading Pneumonectomy Case-Control Studies Research Design Transplantation, Autologous Postoperative Period Brachytherapy Risk Pilot Projects Hospitalization Heart Transplantation Hematopoietic Stem Cell Transplantation Gene Expression Profiling Radiotherapy, High-Energy Tumor Burden Double-Blind Method Pancreas Transplantation Infusions, Intravenous Sensitivity and Specificity Amputation Multicenter Studies as Topic Stents Confidence Intervals Coronary Artery Bypass Vascular Surgical Procedures Blotting, Western Bone Marrow Transplantation Pancreatectomy Magnetic Resonance Imaging Limb Salvage Models, Biological Prevalence Digestive System Surgical Procedures Models, Statistical Biopsy Random Allocation Angioplasty, Balloon, Coronary

Phenomena and Processes23

Cell Survival Time Factors Graft Survival Pregnancy Outcome Pregnancy Apoptosis Chi-Square Distribution Graft Rejection Signal Transduction Probability Recovery of Function Gene Expression Regulation, Neoplastic Cell Proliferation Dose-Response Relationship, Drug Mutation Odds Ratio Risk Tissue Survival Gestational Age Sensitivity and Specificity Drug Resistance, Neoplasm Microbial Viability Genotype

Disciplines and Occupations4

Outcome Assessment (Health Care)Immunohistochemistry Research Design Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena3

Survival Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence Life Tables Hospital Mortality Cause of Death SEER Program Glasgow Outcome Scale Prevalence

Named Groups4

Infant, Newborn Tissue Donors Survivors Living Donors

Health Care64

Survival Rate Treatment Outcome Survival Analysis Disease-Free Survival Retrospective Studies Follow-Up Studies Outcome Assessment (Health Care)Kaplan-Meier Estimate Proportional Hazards Models Prospective Studies Risk Factors Multivariate Analysis Cohort Studies Age Factors Risk Assessment Predictive Value of Tests Registries Outcome and Process Assessment (Health Care)Actuarial Analysis Severity of Illness Index Incidence Chi-Square Distribution Randomized Controlled Trials as Topic Life Tables Patient Selection Logistic Models Treatment Failure Analysis of Variance Hospital Mortality Regression Analysis Sex Factors Probability Cause of Death Length of Stay Clinical Trials as Topic Preoperative Care SEER Program Statistics, Nonparametric Longitudinal Studies Glasgow Outcome Scale Palliative Care Odds Ratio Feasibility Studies Reproducibility of Results Postoperative Care Case-Control Studies Postoperative Period Risk Pilot Projects Hospitalization Cost-Benefit Analysis Patient Outcome Assessment Age Distribution Double-Blind Method Sensitivity and Specificity Multicenter Studies as Topic Confidence Intervals Patient Satisfaction Waiting Lists Prevalence Tissue and Organ Procurement Models, Statistical Random Allocation Emergency Medical Services

Geographicals9

United States Japan France Europe Great Britain Italy China England Germany

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Treatment Outcome Cell Survival Survival Analysis Disease-Free Survival Retrospective Studies Prognosis Follow-Up Studies Outcome Assessment (Health Care)Time Factors Survival Graft Survival Kaplan-Meier Estimate Neoplasm Staging Pregnancy Outcome Combined Modality Therapy Proportional Hazards Models Prospective Studies Risk Factors Neoplasm Recurrence, Local Antineoplastic Combined Chemotherapy Protocols Multivariate Analysis Cohort Studies Postoperative Complications Lung Neoplasms Recurrence Age Factors Liver Neoplasms Risk Assessment Predictive Value of Tests Adenocarcinoma Registries Outcome and Process Assessment (Health Care)Tumor Markers, Biological Liver Transplantation Disease Progression Chemotherapy, Adjuvant Infant, Newborn Antineoplastic Agents Breast Neoplasms Actuarial Analysis Reoperation Pregnancy Severity of Illness Index Lymphatic Metastasis Immunohistochemistry Cisplatin Carcinoma, Squamous Cell Neoplasm Metastasis Apoptosis Carcinoma, Hepatocellular Incidence United States Hepatectomy Radiotherapy, Adjuvant Chi-Square Distribution Kidney Transplantation Cyclophosphamide Vincristine Randomized Controlled Trials as Topic Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Doxorubicin Remission Induction Quality of Life Life Tables Graft Rejection Patient Selection Brain Neoplasms Fluorouracil Radiotherapy Dosage Neoplasm Invasiveness Transplantation, Homologous Cell Line, Tumor Colorectal Neoplasms Neoplasms Pancreatic Neoplasms Logistic Models Treatment Failure Esophageal Neoplasms Heart Arrest Analysis of Variance Carcinoma Tissue Donors Cardiopulmonary Resuscitation Hospital Mortality Regression Analysis Signal Transduction Disease Models, Animal Immunosuppressive Agents Acute Disease Sex Factors Mice, Inbred C57BL Prednisone Probability Drug Administration Schedule Japan Kidney Failure, Chronic Cause of Death Length of Stay

No FAQ available that match "outcomes survival rate"